Kuang Lisha, Ren Cheng, Liao Xiuqing, Zhang Xiaobin, Zhou Xuegang
Department of Health Management Center, Chongqing University Fuling Hospital, Chongqing, People's Republic of China.
Department of Respiratory and Critical Care Medicine, Chongqing University Fuling Hospital, Chongqing, People's Republic of China.
J Asthma Allergy. 2023 Jul 13;16:711-722. doi: 10.2147/JAA.S414164. eCollection 2023.
Previous studies indicate that the percent recovery index (PRI: the percentage increase from the maximally reduced FEV1 after bronchodilator inhalation), one of the indexes of methacholine bronchial provocation, may predict acute asthma exacerbations in childhood and elderly asthmatics. It is known that childhood (<12) and elder (>60) asthmatics may be different to adult patients in many aspect including prognosis. However, in adults, a research for predicting value of PRI to exacerbation is still absence. Besides exacerbation, predicting value of PRI to poor asthma control is also unknown. We try to detect whether PRI can predict poor asthma control and exacerbation in adults in this research. Meanwhile, we try to detect whether treatment can influence PRI.
In 61 adults with asthma, baseline PRI was measured during enrollment. And then baseline PRI was evaluated as a predictor of exacerbation or poor asthma control at an upcoming 3-month follow-up. The covariates included age, sex, BMI, previous exacerbation, smoking status and baseline lung function. After treatment for 3 months, PRI was measured again and compared with baseline PRI.
After the 3-month follow-up, we found that baseline PRI was significantly related to asthma exacerbation (P = 0.023), poor asthma control (ACT at 3 months, P = 0.014), decreased quality of life (decrease of MiniAQLQ, P = 0.010) and cumulative number of EDHO at 3 months (P = 0.039). Meanwhile, no significant correlation was observed between baseline PRI and inflammation factors (FENO, CaNO, and EOS). Finally, PRI was dramatically reduced after standard treatment for 3 months.
PRI is efficient in the prediction of poor asthma control and exacerbation in adults. The predictive value of PRI may rely on the inherent property of asthmatic airway smooth muscle (ASM) independent of inflammation factors. Effective treatment can alleviate PRI dramatically and that indicate PRI may also be valuable in evaluation of curative effect.
先前的研究表明,作为乙酰甲胆碱支气管激发试验指标之一的恢复百分比指数(PRI:吸入支气管扩张剂后FEV1从最大降低值增加的百分比),可能预测儿童和老年哮喘患者的急性哮喘发作。众所周知,儿童(<12岁)和老年(>60岁)哮喘患者在包括预后在内的许多方面可能与成年患者不同。然而,在成年人中,关于PRI对发作的预测价值的研究仍然缺乏。除了发作之外,PRI对哮喘控制不佳的预测价值也尚不清楚。在本研究中,我们试图检测PRI是否能预测成年患者哮喘控制不佳和发作。同时,我们试图检测治疗是否会影响PRI。
在61例成年哮喘患者中,入组时测量基线PRI。然后将基线PRI评估为未来3个月随访时发作或哮喘控制不佳的预测指标。协变量包括年龄、性别、BMI、既往发作史、吸烟状况和基线肺功能。治疗3个月后,再次测量PRI并与基线PRI进行比较。
3个月随访后,我们发现基线PRI与哮喘发作(P = 0.023)、哮喘控制不佳(3个月时的ACT,P = 0.014)、生活质量下降(MiniAQLQ降低,P = 0.010)以及3个月时的急诊就诊累计次数(P = 0.039)显著相关。同时,未观察到基线PRI与炎症因子(FENO、CaNO和EOS)之间存在显著相关性。最后,标准治疗3个月后PRI显著降低。
PRI在预测成年患者哮喘控制不佳和发作方面是有效的。PRI的预测价值可能依赖于哮喘气道平滑肌(ASM)的固有特性,而与炎症因子无关。有效的治疗可显著减轻PRI,这表明PRI在评估治疗效果方面也可能有价值。